0.31%QQQQ 43.45 
0.48%XLF 21.74 3.62%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
RARITAN, N.J. - Johnson & Johnson on Friday said the Food and Drug Administration approved expanding the use of its attention deficit hyperactivity disorder pill Concerta to adults.
The once-daily drug is already approved for children and adolescents ages 6 to 17.
J&J said Concerta is manufactured using a proprietary delivery technology that allows for controlled delivery of the drug.
The active ingredient in Concerta is methylphenidate, the same compound in Novartis AG's Ritalin LA.
In afternoon trading, J&J shares rose 5 cents to $64.31.
(This version CORRECTS 2nd graf to read that Concerta had been on the market for children ages 6 to 17, not 18).)
The above adage is well known by precious-metals investors; in fact I used this quote in one of our monthly reports. I recall how many inquiries ...
The review was scathing. "She cannot sing very well," it said. "She is flat a go...
IN THE HEADLINES McCain caps GOP convention vowing 'change is coming' to Washing...
|
Professional Website Design For Corporate - Get a Free Quote Today
Partners  
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
